1. Acute toxicity and antitumor potential of 1,3,4‐trisubstituted‐1,2,3‐triazole dhmtAc‐loaded liposomes on a triple‐negative breast cancer model
   Jonas P. Ramos et al, 2022, Archiv der Pharmazie CrossRef
2. 4-(N-Phthalimido)phenyl Isonitrile as a Novel Convertible Isocyanide Analogue with the Odorless Property as an Extra Bonus
   Mohammed Salah Ayoup et al, 2023, ACS Omega CrossRef
3. Eribulin Mesylate Improves Cisplatin-Induced Cytotoxicity of Triple-Negative Breast Cancer by Extracellular Signal-Regulated Kinase 1/2 Activation
   Hyemi Ko et al, 2022, Medicina CrossRef
4. Recent Advances in the Development of Thalidomide-Related Compounds as Anticancer Drugs
   Alexia Barbarossa et al, 2022, Current Medicinal Chemistry CrossRef
5. Thiazole, Isatin and Phthalimide Derivatives Tested in vivo against Cancer Models: A Literature Review of the Last Six Years
   Aline Ferreira Pinto et al, 2024, Current Medicinal Chemistry CrossRef
6. Highly Promising Antitumor Agent of a Novel Platinum(II) Complex Bearing a Tetradentate Chelating Ligand
   Ismail Yılmaz et al, 2020, ACS Medicinal Chemistry Letters CrossRef
7. IKZF3 amplification frequently occurs in HER2-positive breast cancer and is a potential therapeutic target
   Chih-Yi Lin et al, 2022, Medical Oncology CrossRef